About GENOMTEC
Sector
Industry
CEO
Miron Tokarski
Website
Headquarters
Wroclaw
Founded
2016
ISIN
PLGNMTC00017
FIGI
BBG00ZNLD9P9
Genomtec SA engages in the research and development of molecular diagnostic equipment. It offers mobile molecular analyzer. The company was founded by Miron Tokarski, Malgorzata Malodobra-Mazur, and Henryk Roguszczak in December 2016 and is headquartered in Wroclaw, Poland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GMT is 11.82 PLN — it has decreased by 2.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange GENOMTEC stocks are traded under the ticker GMT.
GMT stock is 5.72% volatile and has beta coefficient of −0.55. Check out the list of the most volatile stocks — is GENOMTEC there?
Yes, you can track GENOMTEC financials in yearly and quarterly reports right on TradingView.
GMT stock has fallen by 8.51% compared to the previous week, the month change is a 10.47% rise, over the last year GENOMTEC has showed a 31.33% increase.
GMT net income for the last quarter is −2.71 M PLN, while the quarter before that showed −2.08 M PLN of net income which accounts for −30.21% change. Track more GENOMTEC financial stats to get the full picture.
Today GENOMTEC has the market capitalization of 148.57 M, it has decreased by 7.39% over the last week.
No, GMT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GMT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMTEC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMTEC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMTEC stock shows the strong buy signal. See more of GENOMTEC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.